查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1124833

藥物研發服務的全球市場:2022年～2032年

Drug Discovery Services Market Report 2022-2032
出版日期: | 出版商: Visiongain Reports Ltd. | 英文 689 Pages | 商品交期: 最快1-2個工作天內

價格

全球藥物研發服務的市場規模，2022年價值141億7,000萬美元，在預測期間(2022年～2032年)預計以15.17％的年複合成長率成長。藥物研發服務市場，含中東、非洲各國和亞太地區各國，由於新興國家的疾病負擔增加預計擴大。

本報告提供全球藥物研發服務市場相關調查分析，市場概要，COVID-19影響，收益預測，競爭情形，主要企業等相關之最新資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 重要考察

第4章 市場概要

  • 主要調查結果
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • COVID-19影響分析
  • 波特的五力分析
  • PESTEL分析

第5章 全球藥物研發服務市場分析:各服務形式

  • 主要調查結果
  • 服務類型市場區隔的成長預測
  • 全球藥物研發服務市場佔有率:各服務形式
  • 全球藥物研發服務市場規模的估計與預測:各服務形式
  • 化學服務
  • 藥物動力學(DMPK)
  • 生物學服務

第6章 全球藥物研發服務市場分析:各流程

  • 主要調查結果
  • 流程市場區隔的成長預測
  • 全球藥物研發服務市場佔有率:各流程
  • 安全打to領導鑑定
  • 先導藥物最適化
  • 目標選擇
  • 目標檢驗
  • 候補檢驗
  • 全球藥物研發服務市場規模的估計與預測:各流程

第7章 全球藥物研發服務市場分析:各藥物類型

  • 主要調查結果
  • 藥物類型市場區隔的成長預測
  • 全球藥物研發服務市場佔有率:各藥物類型
  • 低分子
  • 生物製藥
  • 全球藥物研發服務市場規模的估計與預測:各藥物類型

第8章 全球藥物研發服務市場分析:各治療領域

  • 主要調查結果
  • 治療領域市場區隔的成長預測
  • 全球藥物研發服務市場佔有率:各治療領域
  • 腫瘤
  • 神經疾病
  • 感染疾病、免疫系疾病
  • 心血管疾病
  • 呼吸疾病
  • 消化器官系統疾病
  • 其他
  • 全球藥物研發服務市場規模的估計與預測:各治療領域

第9章 全球藥物研發服務市場分析:各技術

  • 主要調查結果
  • 技術市場區隔的成長預測
  • 全球藥物研發服務市場佔有率:各技術
  • 高通量篩檢
  • 生物晶片
  • 奈米技術
  • 光譜學
  • 藥物基因體學、藥物遺傳學
  • 其他
  • 全球藥物研發服務市場規模的估計與預測:各技術

第10章 全球藥物研發服務市場分析:各終端用戶

  • 主要調查結果
  • 終端用戶市場區隔的成長預測
  • 全球藥物研發服務市場佔有率:各終端用戶
  • 製藥企業、生物科技企業
  • 學術機構、研究機關
  • 其他
  • 全球藥物研發服務市場規模的估計與預測:各終端用戶

第11章 全球藥物研發服務市場分析:各地區

  • 主要調查結果
  • 地區的市場規模的估計與預測
  • COVID-19影響分析:復甦設想情境(V，U，W，L)

第12章 北美的藥物研發服務市場分析

第13章 歐洲的藥物研發服務市場分析

第14章 亞太地區的藥物研發服務市場分析

第15章 南美的藥物研發服務市場分析

第16章 中東、非洲的藥物研發服務市場分析

第17章 企業簡介

  • 企業佔有率分析
  • Labcorp Drug Development(Parent Company Laboratory Corporation of America Holdings)
  • Eurofins Scientific
  • Charles River Laboratories International, Inc.
  • Evotec AG
  • WuXi AppTec
  • Thermo Fisher Scientific Inc.
  • Jubilant Pharmova Limited Company
  • Domainex
  • Sygnature Discovery
  • BioBlocks, Inc

第18章 結論與建議

Product Code: PHA1180

The global drug discovery services market is anticipated to be valued at US$14.17 billion in 2022 and is projected to grow at a CAGR of 15.17% during the forecast period 2022-2032.

The Drug Discovery Services Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising Prevalence of Chronic Diseases to Boost Market Growth Through 2032

The market for drug discovery services is expected to expand due to the rising disease burden in emerging nations, which includes several Middle Eastern and African nations as well as Asia-Pacific nations. These developing nations deal with a wide range of illnesses, including skin conditions, cancer, HIV, cardiovascular, and neurological conditions. It is anticipated that applications for drug discovery services will aid in the control of these illnesses by extending the reach of treatment, assisting patients in following prescribed treatment plans and increasing public awareness of epidemics.

Additionally, COVID-19 offers a chance for the provider of drug discovery services to take on a larger role in healthcare. Over the course of the forecast period, new revenue opportunities for market players are anticipated to be created by the rising number of coronavirus cases around the world and the expanding interaction between technology and healthcare.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the drug discovery services market evolving?
  • What is driving and restraining the drug discovery services market?
  • How will each drug discovery services submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
  • How will the market shares for each drug discovery services submarket develop from 2022 to 2032?
  • What will be the main driver for the overall market from 2022 to 2032?
  • Will leading drug discovery services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2020 and 2032? What are the implications of drug discovery services projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the drug discovery services market?
  • Where is the drug discovery services market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the drug discovery services market today, and over the next 10 years:

  • Our 689-page report provides 259 tables and 493 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the drug discovery services market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising drug discovery services prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Services Type Outlook

  • Chemistry Services
  • Drug Metabolism and Pharmacokinetics (DMPK)
  • Biology Services

Process

  • Hit to Lead Identification
  • Lead Optimization
  • Target Selection
  • Target Validation
  • Candidate Validation

Drug Type

  • Small Molecules
  • Biologics

Therapeutic Area

  • Oncology
  • Neurology
  • Infectious and Immune System Diseases
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Digestive System Diseases
  • Other Therapeutic Areas

Technology

  • High Throughput Screening
  • Biochips
  • Nanotechnology
  • Spectroscopy
  • Pharmacogenomics and Pharmacogenetics
  • Others

End-user

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • Spain
  • United Kingdom
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Colombia
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Drug Discovery

Services Market, 2022 to 2032, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • BioBlocks, Inc
  • Charles River Laboratories
  • Domainex
  • Eurofins Scientific
  • Evotec
  • Jubilant Pharmova Limited Company
  • Labcorp Drug Development (Parent Company Laboratory Corporation of America Holdings)
  • Thermo Fisher Scientific Inc.
  • Sygnature Discovery
  • WuXi AppTec

Overall world revenue for drug discovery services market, 2022 to 2032 in terms of value the market will surpass US$14 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Drug Discovery Services Market, 2022 to 2032 report help you?

In summary, our 680+ page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Drug Discovery Services Market, 2022 to 2032 Market, with forecasts for service type, process, drug type, therapeutic area, technology, and end-user each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2032 for four regional and 23 key national markets - See forecasts for the Drug Discovery Services Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Drug Discovery Services Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the drug discovery services market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Drug Discovery Services Market
  • 1.3 What this Report Delivers
  • 1.4 Why You Should Read this Report
  • 1.5 Key Questions Answered by this Analytical Report Include:
  • 1.6 Who is this Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation

1.7.3.1 Primary Research

1.7.3.2 Secondary Research

  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Premium Insights

  • 3.1 Geographical Snapshot: Global Drug Discovery Services Market
  • 3.2 Services Segment: Market Attractiveness Index
  • 3.3 Process Segment: Market Attractiveness Index
  • 3.4 Drug Type Segment: Market Attractiveness Index
  • 3.5 Therapeutic Area Segment: Market Attractiveness Index
  • 3.6 Technology Segment: Market Attractiveness Index
  • 3.7 End User Segment: Market Attractiveness Index

4 Market Overview

  • 4.1 Key Findings
  • 4.2 Market Dynamics
    • 4.2.1 Market Driving Factors

4.2.1.1 Rising Prevalence of Chronic Diseases

4.2.1.2 Increase in Research & Development Expenditure for Novel Drug Development

4.2.1.3 High Demand of Outsourcing Clinical Trial Services

    • 4.2.2 Market Restraining Factors

4.2.2.1 Stringent Government Regulations or Approval of New Drug

4.2.2.2 High Cost Associated with New Drug Development

4.2.2.3 High Risk of Failure and Time Consuming Process

    • 4.2.3 Market Opportunities

4.2.3.1 Rise in Healthcare Expenditure

4.2.3.2 Intervention of Artificial Intelligence for Drug Discovery

4.2.3.3 Rise in Growth of Drugs and Biologics

  • 4.3 COVID-19 Impact Analysis
    • 4.3.1 V-Shaped Recovery
    • 4.3.2 U-Shaped Recovery
    • 4.3.3 W-Shaped Recovery
    • 4.3.4 L-Shaped Recovery
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Competitor Rivalry
    • 4.4.2 Threat of Substitute Products
    • 4.4.3 Bargaining Power of Buyers
    • 4.4.4 Threat of New Entrants
    • 4.4.5 Bargaining Power of Suppliers
  • 4.5 PESTEL Analysis

5 Global Drug Discovery Services Market Analysis by Services Type

  • 5.1 Key Findings
  • 5.2 Services Type Segment Growth Prospects
  • 5.3 Global Drug Discovery Services Market Share by Services Type, 2022 & 2032
  • 5.4 Global Drug Discovery Services Market Size Estimation and Forecast by Services Type
  • 5.5 Chemistry Services
    • 5.5.1 Chemistry Services Market Forecast by Region, 2022-2032 (US$ Bn)
    • 5.5.2 Chemistry Services Market Share by Region, 2022 & 2032 (%)
  • 5.6 Drug Metabolism and Pharmacokinetics (DMPK)
    • 5.6.1 Drug Metabolism and Pharmacokinetics (DMPK) Market Forecast by Region, 2022-2032 (US$ Bn)
    • 5.6.2 Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region, 2022 & 2032 (%)
  • 5.7 Biology Services
    • 5.7.1 Biology Services Market Forecast by Region, 2022-2032 (US$ Bn)
    • 5.7.2 Biology Services Market Share by Region, 2022 & 2032 (%)

6 Global Drug Discovery Services Market Analysis by Process

  • 6.1 Key Findings
  • 6.2 Process Segment Growth Prospects
  • 6.3 Global Drug Discovery Services Market Share by Process, 2022 & 2032
  • 6.4 Hit to Lead Identification
    • 6.4.1 Hit to Lead Identification Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.4.2 Hit to Lead Identification Market Share by Region, 2022 & 2032 (%)
  • 6.5 Lead Optimization
    • 6.5.1 Lead Optimization Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.5.2 Lead Optimization Market Share by Region, 2022 & 2032 (%)
  • 6.6 Target Selection
    • 6.6.1 Target Selection Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.6.2 Target Selection Market Share by Region, 2022 & 2032 (%)
  • 6.7 Target Validation
    • 6.7.1 Target Validation Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.7.2 Target Validation Market Share by Region, 2022 & 2032 (%)
  • 6.8 Candidate Validation
    • 6.8.1 Candidate Validation Market Forecast by Region, 2022-2032 (US$ Bn)
    • 6.8.2 Candidate Validation Market Share by Region, 2022 & 2032 (%)
  • 6.9 Global Drug Discovery Services Market Size Estimation and Forecast by Process

7 Global Drug Discovery Services Market Analysis by Drug Type

  • 7.1 Key Findings
  • 7.2 Drug Type Segment Growth Prospects
  • 7.3 Global Drug Discovery Services Market Share by Drug Type, 2022 & 2032
  • 7.4 Small Molecules
    • 7.4.1 Small Molecules Market Forecast by Region, 2022-2032 (US$ Bn)
    • 7.4.2 Small Molecules Market Share by Region, 2022 & 2032 (%)
  • 7.5 Biologics
    • 7.5.1 Biologics Market Forecast by Region, 2022-2032 (US$ Bn)
    • 7.5.2 Biologics Market Share by Region, 2022 & 2032 (%)
  • 7.6 Global Drug Discovery Services Market Size Estimation and Forecast by Drug Type

8 Global Drug Discovery Services Market Analysis by Therapeutic Area

  • 8.1 Key Findings
  • 8.2 Therapeutic Area Segment Growth Prospects
  • 8.3 Global Drug Discovery Services Market Share by Therapeutic Area, 2022 & 2032
  • 8.4 Oncology
    • 8.4.1 Oncology Market Forecast by Region, 2022-2032 (US$ Bn)
    • 8.4.2 Oncology Market Share by Region, 2022 & 2032 (%)
  • 8.5 Neurology
    • 8.5.1 Neurology Market Forecast by Region, 2022-2032 (US$ Bn)
    • 8.5.2 Neurology Market Share by Region, 2022 & 2032 (%)
  • 8.6 Infectious and Immune System Diseases
    • 8.6.1 Infectious and Immune System Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
    • 8.6.2 Infectious and Immune System Diseases Market Share by Region, 2022 & 2032 (%)
  • 8.7 Cardiovascular Diseases
    • 8.7.1 Cardiovascular Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
    • 8.7.2 Cardiovascular Diseases Market Share by Region, 2022 & 2032 (%)
  • 8.8 Respiratory Diseases
    • 8.8.1 Respiratory Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
    • 8.8.2 Respiratory Diseases Market Share by Region, 2022 & 2032 (%)
  • 8.9 Digestive System Diseases
    • 8.9.1 Digestive System Diseases Market Forecast by Region, 2022-2032 (US$ Bn)
    • 8.9.2 Digestive System Diseases Market Share by Region, 2022 & 2032 (%)
  • 8.10 Other Therapeutic Areas
    • 8.10.1 Other Therapeutic Areas Market Forecast by Region, 2022-2032 (US$ Bn)
    • 8.10.2 Other Therapeutic Areas Market Share by Region, 2022 & 2032 (%)
  • 8.11 Global Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area

9 Global Drug Discovery Services Market Analysis by Technology

  • 9.1 Key Findings
  • 9.2 Technology Segment Growth Prospects
  • 9.3 Global Drug Discovery Services Market Share by Technology, 2022 & 2032
  • 9.4 High Throughput Screening
    • 9.4.1 High Throughput Screening Market Forecast by Region, 2022-2032 (US$ Bn)
    • 9.4.2 High Throughput Screening Market Share by Region, 2022 & 2032 (%)
  • 9.5 Biochips
    • 9.5.1 Biochips Market Forecast by Region, 2022-2032 (US$ Bn)
    • 9.5.2 Biochips Market Share by Region, 2022 & 2032 (%)
  • 9.6 Nanotechnology
    • 9.6.1 Nanotechnology Market Forecast by Region, 2022-2032 (US$ Bn)
    • 9.6.2 Nanotechnology Market Share by Region, 2022 & 2032 (%)
  • 9.7 Spectroscopy
    • 9.7.1 Spectroscopy Market Forecast by Region, 2022-2032 (US$ Bn)
    • 9.7.2 Spectroscopy Market Share by Region, 2022 & 2032 (%)
  • 9.8 Pharmacogenomics and Pharmacogenetics
    • 9.8.1 Pharmacogenomics and Pharmacogenetics Market Forecast by Region, 2022-2032 (US$ Bn)
    • 9.8.2 Pharmacogenomics and Pharmacogenetics Market Share by Region, 2022 & 2032 (%)
  • 9.9 Others
    • 9.9.1 Others Market Forecast by Region, 2022-2032 (US$ Bn)
    • 9.9.2 Others Market Share by Region, 2022 & 2032 (%)
  • 9.10 Global drug discovery services market Size Estimation and Forecast by Technology

10 Global Drug Discovery Services Market Analysis by End User

  • 10.1 Key Findings
  • 10.2 End User Segment Growth Prospects
  • 10.3 Global Drug Discovery Services Market Share by End User, 2022 & 2032
  • 10.4 Pharmaceutical and Biotechnology Companies
    • 10.4.1 Pharmaceutical and Biotechnology Companies Market Forecast by Region, 2022-2032 (US$ Bn)
    • 10.4.2 Pharmaceutical and Biotechnology Companies Market Share by Region, 2022 & 2032 (%)
  • 10.5 Academic and Research Institutes
    • 10.5.1 Academic and Research Institutes Market Forecast by Region, 2022-2032 (US$ Bn)
    • 10.5.2 Academic and Research Institutes Market Share by Region, 2022 & 2032 (%)
  • 10.6 Others
    • 10.6.1 Others Market Forecast by Region, 2022-2032 (US$ Bn)
    • 10.6.2 Others Market Share by Region, 2022 & 2032 (%)
  • 10.7 Global Drug Discovery Services Market Size Estimation and Forecast by End User

11 Global Drug Discovery Services Market Analysis by Region

  • 11.1 Key Findings
  • 11.2 Regional Market Size Estimation and Forecast
  • 11.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

12 North America Drug Discovery Services Market Analysis

  • 12.1 Key Findings
  • 12.2 North America Drug discovery services Market Attractiveness Index
  • 12.3 North America Drug Discovery Services Market by Country, 2022, 2027 & 2032 (US$ Bn)
  • 12.4 North America Drug Discovery Services Market Size Estimation and Forecast by Country
  • 12.5 North America Drug discovery services Market Size Estimation and Forecast by Services Type
  • 12.6 North America Drug discovery services Market Size Estimation and Forecast by Process
  • 12.7 North America Drug Discovery Services Market Size Estimation and Forecast by Drug Type
  • 12.8 North America Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
  • 12.9 North America Drug Discovery Services Market Size Estimation and Forecast by Technology
  • 12.10 North America Drug Discovery Services Market Size Estimation and Forecast by End User
  • 12.11 U.S. Drug Discovery Services Market Estimation & Forecast
    • 12.11.1 U.S. Drug discovery services Market by Services Type
    • 12.11.2 U.S. Drug Discovery Services Market by Process
    • 12.11.3 U.S. Drug Discovery Services Market by Drug Type
    • 12.11.4 U.S. Drug Discovery Services Market by Therapeutic Area
    • 12.11.5 U.S. Drug Discovery Services Market by Technology
    • 12.11.6 U.S. Drug Discovery Services Market by End User
  • 12.12 Canada Drug Discovery Services Market Estimation & Forecast
    • 12.12.1 Canada Drug Discovery Services Market by Services Type
    • 12.12.2 Canada Drug Discovery Services Market by Process
    • 12.12.3 Canada Drug Discovery Services Market by Drug Type
    • 12.12.4 Canada Drug Discovery Services Market by Therapeutic Area
    • 12.12.5 Canada Drug Discovery Services Market by Technology
    • 12.12.6 Canada Drug Discovery Services Market by End User

13 Europe Drug discovery services Market Analysis

  • 13.1 Key Findings
  • 13.2 Europe Drug Discovery Services Market Attractiveness Index
  • 13.3 Europe Drug Discovery Services Market by Country, 2022, 2027 & 2032 (US$ Bn)
  • 13.4 Europe Drug discovery services Market Size Estimation and Forecast by Country
  • 13.5 Europe Drug Discovery Services Market Size Estimation and Forecast by Services Type
  • 13.6 Europe Drug Discovery Services Market Size Estimation and Forecast by Process
  • 13.7 Europe Drug Discovery Services Market Size Estimation and Forecast by Drug Type
  • 13.8 Europe Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
  • 13.9 Europe Drug Discovery Services Market Size Estimation and Forecast By Technology
  • 13.10 Europe Drug Discovery Services Market Size Estimation and Forecast by End User
  • 13.11 Germany Drug Discovery Services Market Estimation & Forecast
    • 13.11.1 Germany Drug Discovery Services Market by Services Type
    • 13.11.2 Germany Drug Discovery Services Market by Process
    • 13.11.3 Germany Drug Discovery Services Market by Drug Type
    • 13.11.4 Germany Drug Discovery Services Market by Therapeutic Area
    • 13.11.5 Germany Drug Discovery Services Market by Technology
    • 13.11.6 Germany Drug Discovery Services Market by End User
  • 13.12 U.K. Drug Discovery Services Market Estimation & Forecast
    • 13.12.1 U.K. Drug Discovery Services Market by Services Type
    • 13.12.2 U.K. Drug Discovery Services Market by Process
    • 13.12.3 U.K. Drug Discovery Services Market by Drug Type
    • 13.12.4 U.K. Drug Discovery Services Market by Therapeutic Area
    • 13.12.5 U.K. Drug Discovery Services Market by Technology
    • 13.12.6 U.K. Drug Discovery Services Market by End User
  • 13.13 France Drug Discovery Services Market Estimation & Forecast
    • 13.13.1 France Drug Discovery Services Market by Services Type
    • 13.13.2 France Drug Discovery Services Market by Process
    • 13.13.3 France Drug Discovery Services Market by Drug Type
    • 13.13.4 France Drug Discovery Services Market by Therapeutic Area
    • 13.13.5 France Drug Discovery Services Market by Technology
    • 13.13.6 France Drug Discovery Services Market by End User
  • 13.14 Italy Drug Discovery Services Market Estimation & Forecast
    • 13.14.1 Italy Drug Discovery Services Market by Services Type
    • 13.14.2 Italy Drug Discovery Services Market by Process
    • 13.14.3 Italy Drug Discovery Services Market by Drug Type
    • 13.14.4 Italy Drug Discovery Services Market by Therapeutic Area
    • 13.14.5 Italy Drug Discovery Services Market by Technology
    • 13.14.6 Italy Drug Discovery Services Market by End User
  • 13.15 Spain Drug Discovery Services Market Estimation & Forecast
    • 13.15.1 Spain Drug Discovery Services Market by Services Type
    • 13.15.2 Spain Drug Discovery Services Market by Process
    • 13.15.3 Spain Drug Discovery Services Market by Drug Type
    • 13.15.4 Spain Drug Discovery Services Market by Therapeutic Area
    • 13.15.5 Spain Drug Discovery Services Market by Technology
    • 13.15.6 Spain Drug Discovery Services Market by End User
  • 13.16 Rest of Europe Drug Discovery Services Market Estimation & Forecast
    • 13.16.1 Rest of Europe Drug Discovery Services Market by Services Type
    • 13.16.2 Rest of Europe Drug Discovery Services Market by Process
    • 13.16.3 Rest of Europe Drug Discovery Services Market by Drug Type
    • 13.16.4 Rest of Europe Drug Discovery Services Market by Therapeutic Area
    • 13.16.5 Rest of Europe Drug Discovery Services Market by Technology
    • 13.16.6 Rest of Europe Drug Discovery Services Market by End User

14 Asia Pacific Drug discovery services Market Analysis

  • 14.1 Key Findings
  • 14.2 Asia Pacific Drug Discovery Services Market Attractiveness Index
  • 14.3 Asia Pacific Drug Discovery Services Market By Country, 2022, 2027 & 2032 (US$ Bn)
  • 14.4 Asia Pacific Drug discovery services Market Size Estimation and Forecast by Country
  • 14.5 Asia Pacific Drug discovery services Market Size Estimation and Forecast by Services Type
  • 14.6 Asia Pacific Drug discovery services Market Size Estimation and Forecast by Process
  • 14.7 Asia Pacific Drug Discovery Services Market Size Estimation and Forecast by Drug Type
  • 14.8 Asia Pacific Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
  • 14.9 Asia Pacific Drug Discovery Services Market Size Estimation and Forecast By Technology
  • 14.10 Asia Pacific Drug Discovery Services Market Size Estimation and Forecast By End User
  • 14.11 China Drug Discovery Services Market Estimation & Forecast
    • 14.11.1 China Drug discovery services Market by Services Type
    • 14.11.2 China Drug discovery services Market by Process
    • 14.11.3 China Drug discovery services Market by Drug Type
    • 14.11.4 China Drug discovery services Market by Therapeutic Area
    • 14.11.5 China Drug discovery services Market by Technology
    • 14.11.6 China Drug discovery services Market by End User
  • 14.12 Japan Drug Discovery Services Market Estimation & Forecast
    • 14.12.1 Japan Drug Discovery Services Market by Services Type
    • 14.12.2 Japan Drug Discovery Services Market by Process
    • 14.12.3 Japan Drug Discovery Services Market by Drug Type
    • 14.12.4 Japan Drug Discovery Services Market by Therapeutic Area
    • 14.12.5 Japan Drug Discovery Services Market by Technology
    • 14.12.6 Japan Drug Discovery Services Market by End User
  • 14.13 India Drug Discovery Services Market Estimation & Forecast
    • 14.13.1 India Drug Discovery Services Market by Services Type
    • 14.13.2 India Drug Discovery Services Market by Process
    • 14.13.3 India Drug Discovery Services Market by Drug Type
    • 14.13.4 India Drug Discovery Services Market by Therapeutic Area
    • 14.13.5 India Drug Discovery Services Market by Technology
    • 14.13.6 India Drug Discovery Services Market by End User
  • 14.14 South Korea Drug Discovery Services Market Estimation & Forecast
    • 14.14.1 South Korea Drug Discovery Services Market by Services Type
    • 14.14.2 South Korea Drug Discovery Services Market by Process
    • 14.14.3 South Korea Drug Discovery Services Market by Drug Type
    • 14.14.4 South Korea Drug Discovery Services Market by Therapeutic Area
    • 14.14.5 South Korea Drug Discovery Services Market by Technology
    • 14.14.6 South Korea Drug Discovery Services Market by End User
  • 14.15 Australia Drug Discovery Services Market Estimation & Forecast
    • 14.15.1 Australia Drug Discovery Services Market by Services Type
    • 14.15.2 Australia Drug Discovery Services Market by Process
    • 14.15.3 Australia Drug Discovery Services Market by Drug Type
    • 14.15.4 Australia Drug Discovery Services Market by Therapeutic Area
    • 14.15.5 Australia Drug discovery services Market by Technology
    • 14.15.6 Australia Drug Discovery Services Market by End User
  • 14.16 South East Asia Drug Discovery Services Market Estimation & Forecast
    • 14.16.1 South East Asia Drug Discovery Services Market by Services Type
    • 14.16.2 South East Asia Drug Discovery Services Market by Process
    • 14.16.3 South East Asia Drug Discovery Services Market by Drug Type
    • 14.16.4 South East Asia Drug Discovery Services Market by Therapeutic Area
    • 14.16.5 South East Asia Drug Discovery Services Market by Technology
    • 14.16.6 South East Asia Drug Discovery Services Market by End User
  • 14.17 Rest of Asia Pacific Drug Discovery Services Market Estimation & Forecast
    • 14.17.1 Rest of Asia Pacific Drug Discovery Services Market by Services Type
    • 14.17.2 Rest of Asia Pacific Drug Discovery Services Market by Process
    • 14.17.3 Rest of Asia Pacific Drug Discovery Services Market by Drug Type
    • 14.17.4 Rest of Asia Pacific Drug Discovery Services Market by Therapeutic Area
    • 14.17.5 Rest of Asia Pacific Drug Discovery Services Market by Technology
    • 14.17.6 Rest of Asia Pacific Drug Discovery Services Market by End User

15 Latin America Drug discovery services Market Analysis

  • 15.1 Key Findings
  • 15.2 Latin America Drug Discovery Services Market Attractiveness Index
  • 15.3 Latin America Drug Discovery Services Market by Country, 2022, 2027 & 2032 (US$ Bn)
  • 15.4 Latin America Drug Discovery Services Market Size Estimation and Forecast by Country
  • 15.5 Latin America Drug Discovery Services Market Size Estimation and Forecast by Services Type
  • 15.6 Latin America Drug Discovery Services Market Size Estimation and Forecast by Process
  • 15.7 Latin America Drug Discovery Services Market Size Estimation and Forecast by Drug Type
  • 15.8 Latin America Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
  • 15.9 Latin America Drug Discovery Services Market Size Estimation and Forecast by Technology
  • 15.10 Latin America Drug Discovery Services Market Size Estimation and Forecast by End User
  • 15.11 Brazil Drug Discovery Services Market Estimation & Forecast
    • 15.11.1 Brazil Drug Discovery Services Market by Services Type
    • 15.11.2 Brazil Drug Discovery Services Market by Process
    • 15.11.3 Brazil Drug Discovery Services Market by Drug Type
    • 15.11.4 Brazil Drug Discovery Services Market by Therapeutic Area
    • 15.11.5 Brazil Drug Discovery Services Market by Technology
    • 15.11.6 Brazil Drug Discovery Services Market by End User
  • 15.12 Argentina Drug Discovery Services Market Estimation & Forecast
    • 15.12.1 Argentina Drug Discovery Services Market by Services Type
    • 15.12.2 Argentina Drug Discovery Services Market by Process
    • 15.12.3 Argentina Drug Discovery Services Market by Drug Type
    • 15.12.4 Argentina Drug Discovery Services Market by Therapeutic Area
    • 15.12.5 Argentina Drug Discovery Services Market by Technology
    • 15.12.6 Argentina Drug Discovery Services Market by End User
  • 15.13 Mexico Drug Discovery Services Market Estimation & Forecast
    • 15.13.1 Mexico Drug Discovery Services Market by Services Type
    • 15.13.2 Mexico Drug Discovery Services Market by Process
    • 15.13.3 Mexico Drug Discovery Services Market by Drug Type
    • 15.13.4 Mexico Drug Discovery Services Market by Therapeutic Area
    • 15.13.5 Mexico Drug Discovery Services Market by Technology
    • 15.13.6 Mexico Drug Discovery Services Market by End User
  • 15.14 Colombia Drug Discovery Services Market Estimation & Forecast
    • 15.14.1 Colombia Drug Discovery Services Market by Services Type
    • 15.14.2 Colombia Drug Discovery Services Market by Process
    • 15.14.3 Colombia Drug Discovery Services Market by Drug Type
    • 15.14.4 Colombia Drug Discovery Services Market by Therapeutic Area
    • 15.14.5 Colombia Drug Discovery Services Market by Technology
    • 15.14.6 Colombia Drug Discovery Services Market by End User
  • 15.15 Rest of Latin America Drug Discovery Services Market Estimation & Forecast
    • 15.15.1 Rest of Latin America Drug Discovery Services Market by Services Type
    • 15.15.2 Rest of Latin America Drug Discovery Services Market by Process
    • 15.15.3 Rest of Latin America Drug Discovery Services Market by Drug Type
    • 15.15.4 Rest of Latin America Drug Discovery Services Market by Therapeutic Area
    • 15.15.5 Rest of Latin America Drug Discovery Services Market by Technology
    • 15.15.6 Rest of Latin America Drug Discovery Services Market by End User

16 MEA Drug discovery services Market Analysis

  • 16.1 Key Findings
  • 16.2 MEA Drug Discovery Services Market Attractiveness Index
  • 16.3 MEA Drug Discovery Services Market by Country, 2022, 2027 & 2032 (US$ Bn)
  • 16.4 MEA Drug Discovery Services Market Size Estimation and Forecast by Country
  • 16.5 MEA Drug Discovery Services Market Size Estimation and Forecast by Services Type
  • 16.6 MEA Drug Discovery Services Market Size Estimation and Forecast by Process
  • 16.7 MEA Drug Discovery Services Market Size Estimation and Forecast by Drug Type
  • 16.8 MEA Drug Discovery Services Market Size Estimation and Forecast by Therapeutic Area
  • 16.9 MEA Drug Discovery Services Market Size Estimation and Forecast by Technology
  • 16.10 MEA Drug Discovery Services Market Size Estimation and Forecast by End User
  • 16.11 GCC Drug Discovery Services Market Estimation & Forecast
    • 16.11.1 GCC Drug Discovery Services Market by Services Type
    • 16.11.2 GCC Drug Discovery Services Market by Process
    • 16.11.3 GCC Drug Discovery Services Market by Drug Type
    • 16.11.4 GCC Drug Discovery Services Market by Therapeutic Area
    • 16.11.5 GCC Drug Discovery Services Market by Technology
    • 16.11.6 GCC Drug Discovery Services Market by End User
  • 16.12 South Africa Drug Discovery Services Market Estimation & Forecast
    • 16.12.1 South Africa Drug Discovery Services Market by Services Type
    • 16.12.2 South Africa Drug Discovery Services Market by Process
    • 16.12.3 South Africa Drug Discovery Services Market by Drug Type
    • 16.12.4 South Africa Drug Discovery Services Market by Therapeutic Area
    • 16.12.5 South Africa Drug Discovery Services Market by Technology
    • 16.12.6 South Africa Drug Discovery Services Market by End User
  • 16.13 Rest of MEA Drug Discovery Services Market Estimation & Forecast
    • 16.13.1 Rest of MEA Drug Discovery Services Market by Services Type
    • 16.13.2 Rest of MEA Drug Discovery Services Market by Process
    • 16.13.3 Rest of MEA Drug Discovery Services Market by Drug Type
    • 16.13.4 Rest of MEA Drug Discovery Services Market by Therapeutic Area
    • 16.13.5 Rest of MEA Drug Discovery Services Market by Technology
    • 16.13.6 Rest of MEA Drug Discovery Services Market by End User

17 Company Profiles

  • 17.1 Company Share Analysis
  • 17.2 Labcorp Drug Development (Parent Company Laboratory Corporation of America Holdings)
    • 17.2.1 Company Snapshot
    • 17.2.2 Company Overview
    • 17.2.3 Financial Analysis

17.2.3.1 Revenue, 2017-2021

17.2.3.2 Regional Market Shares, 2021

17.2.3.3 Gross Profit, 2017-2021

    • 17.2.4 Product Benchmarking
    • 17.2.5 Strategic Outlook
  • 17.3 Eurofins Scientific
    • 17.3.1 Company Snapshot
    • 17.3.2 Company Overview
    • 17.3.3 Financial Analysis

17.3.3.1 Revenue, 2017-2021

17.3.3.2 Regional Market Shares, 2021

17.3.3.3 Gross Profit, 2017-2021

    • 17.3.4 Product Benchmarking
    • 17.3.5 Strategic Outlook
  • 17.4 Charles River Laboratories International, Inc.
    • 17.4.1 Company Snapshot
    • 17.4.2 Company Overview
    • 17.4.3 Financial Analysis

17.4.3.1 Revenue, 2017-2021

17.4.3.2 Regional Market Shares, 2021

    • 17.4.4 Product Benchmarking
    • 17.4.5 Strategic Outlook
  • 17.5 Evotec AG
    • 17.5.1 Company Snapshot
    • 17.5.2 Company Overview
    • 17.5.3 Financial Analysis

17.5.3.1 Revenue, 2017-2021

17.5.3.2 Gross Profit, 2017-2021

    • 17.5.4 Product Benchmarking
    • 17.5.5 Strategic Outlook
  • 17.6 WuXi AppTec
    • 17.6.1 Company Snapshot
    • 17.6.2 Company Overview
    • 17.6.3 Financial Analysis

17.6.3.1 Revenue, 2015-2021

17.6.3.2 Regional Market Shares, 2021

    • 17.6.4 Product Benchmarking
    • 17.6.5 Strategic Outlook
  • 17.7 Thermo Fisher Scientific Inc.
    • 17.7.1 Company Snapshot
    • 17.7.2 Company Overview
    • 17.7.3 Financial Analysis

17.7.3.1 Revenue, 2017-2021

17.7.3.2 Regional Market Shares, 2021

    • 17.7.4 Product Benchmarking
    • 17.7.5 Strategic Outlook
  • 17.8 Jubilant Pharmova Limited Company
    • 17.8.1 Company Snapshot
    • 17.8.2 Company Overview
    • 17.8.3 Financial Analysis

17.8.3.1 Revenue, 2017-2021

17.8.3.2 Regional Market Shares, 2021

    • 17.8.4 Product Benchmarking
    • 17.8.5 Strategic Outlook
  • 17.9 Domainex
    • 17.9.1 Company Snapshot
    • 17.9.2 Company Overview
    • 17.9.3 Product Benchmarking
    • 17.9.4 Strategic Outlook
  • 17.10 Sygnature Discovery
    • 17.10.1 Company Snapshot
    • 17.10.2 Company Overview
    • 17.10.3 Product Benchmarking
    • 17.10.4 Strategic Outlook
  • 17.11 BioBlocks, Inc
    • 17.11.1 Company Snapshot
    • 17.11.2 Company Overview
    • 17.11.3 Product Benchmarking

18 Conclusion and Recommendations

  • 18.1 Concluding Remarks from
  • 18.2 Recommendations for Market Players

List of Tables

  • Table 1 Global Drug Discovery Services Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
  • Table 2 Global Drug Discovery Services Market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): "V" Shaped Recovery Scenario
  • Table 3 Global drug discovery services market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): "U" Shaped Recovery Scenario
  • Table 4 Global Drug Discovery Services Market By Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): "W" Shaped Recovery Scenario
  • Table 5 Global Drug Discovery Services Market By Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): "L" Shaped Recovery Scenario
  • Table 6 Global Drug Discovery Services Market by Services Type Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 7 Chemistry Services Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 8 Drug Metabolism and Pharmacokinetics (DMPK) Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 9 Biology Services Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 10 Hit to Lead Identification Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 11 Lead Optimization Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 12 Target Selection Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 13 Target Validation Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 14 Candidate Validation Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 15 Global Drug Discovery Services Market by Services Process Forecast, 2022-2032
  • (US$ Bn, AGR%, CAGR%)
  • Table 16 Small Molecules Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 17 Biologics Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 18 Global Drug Discovery Services Market by Drug Type Forecast, 2022-2032
  • (US$ Bn, AGR%, CAGR%)
  • Table 19 Oncology Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 20 Neurology Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 21 Infectious and Immune System Diseases Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 22 Cardiovascular Diseases Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 23 Respiratory Diseases Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 24 Digestive System Diseases Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 25 Other Therapeutic Areas Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 26 Global Drug Discovery Services Market by Therapeutic Area Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 27 High Throughput Screening Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 28 Biochips Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 29 Nanotechnology Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 30 Spectroscopy Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 31 Pharmacogenomics And Pharmacogenetics Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 32 Others Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 33 Global Drug Discovery Services Market by Technology Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 34 Pharmaceutical and Biotechnology Companies Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 35 Academic and Research Institutes Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 36 Others Market Forecast By Region, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 37 Global Drug Discovery Services Market by End User Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 38 Global Drug Discover Services Market by Region Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 39 Global drug discovery services market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): "V" Shaped Recovery Scenario
  • Table 40 Global Drug Discovery Services Market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): "U" Shaped Recovery Scenario
  • Table 41 Global Drug Discovery Services Market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): "W" Shaped Recovery Scenario
  • Table 42 Global Drug Discovery Services Market by Region, 2022-2032 (USD Bn, AGR (%), CAGR(%)): "L" Shaped Recovery Scenario
  • Table 43 North America Drug Discovery Services Market Forecast By Country, 2022-2032 (US$ Billion, AGR (%)
  • Table 44 North America Drug Discovery Services Market by Services Type Forecast,
  • 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 45 North America Drug Discovery Services Market by Services Process Forecast,
  • 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 46 North America Drug Discovery Services Market by Drug Type Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 47 North America Drug Discovery Services Market by Therapeutic Area Forecast,
  • 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 48 North America Drug Discovery Services Market by Technology Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 49 North America Drug Discovery Services Market by End User Forecast, 2022-2032
  • (US$ Mn, AGR%, CAGR%)
  • Table 50 U.S. Drug Discovery Services Market by Country Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 51 U.S. Drug Discovery Services Market by Services Type Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 52 U.S. Drug Discovery Services Market by Process Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 53 U.S. Drug Discovery Services Market by Drug Type Forecast, 2022-2032
  • (US$ Mn, AGR%, CAGR%)
  • Table 54 U.S. Drug Discovery Services Market by Therapeutic Area Forecast, 2022-2032
  • (US$ Mn, AGR%, CAGR%)
  • Table 55 U.S. Drug Discovery Services Market by Technology Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 56 U.S. Drug Discovery Services Market by End User Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 57 Canada Drug Discovery Services Market by Country Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 58 Canada Drug Discovery Services Market by Services Type Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 59 Canada Drug Discovery Services Market by Services Process Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 60 Canada Drug Discovery Services Market by Drug Type Forecast,
  • 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 61 Canada Drug Discovery Services Market by Therapeutic Area Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 62 Canada Drug Discovery Services Market by Technology Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 63 Canada Drug Discovery Services Market by End User Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 64 Europe Drug Discovery Services Market by Country Forecast, 2022-2032
  • (US$ Bn, AGR%, CAGR%)
  • Table 65 Europe Drug Discovery Services Market by Services Type Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 66 Europe Drug Discovery Services Market by Services Process Forecast, 2022-2032 (US$ Bn, AGR%, CAGR%)
  • Table 67 Europe Drug Discovery Services Market by Drug Type Forecast, 2022-2032 (US$ Bn, AGR